INmune Bio Inc. Completes Repayment of Silicon Valley Bank Debt
| INMB Stock | USD 9.22 0.16 1.77% |
About 56% of all INmune Bio's investors are looking to take a long position. The analysis of the overall investor sentiment regarding INmune Bio suggests that some traders are interested. The current market sentiment, together with INmune Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use INmune Bio stock news signals to limit their universe of possible portfolio assets.
INmune |
Boca Raton, Florida, Dec. 10, 2024 -- INmune Bio, Inc. , a clinical-stage inflammation and immunology company foc
Read at gurufocus.com
 |
INmune Bio Fundamental Analysis
We analyze INmune Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INmune Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INmune Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
INmune Bio is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
INmune Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with INmune Bio stock to make a market-neutral strategy. Peer analysis of INmune Bio could also be used in its relative valuation, which is a method of valuing INmune Bio by comparing valuation metrics with similar companies.
Peers
INmune Bio Related Equities
| CUE | Cue Biopharma | 6.62 | ||||
| INAB | In8bio | 4.00 | ||||
| SAVA | Cassava Sciences | 3.03 | ||||
| DRMA | Dermata Therapeutics | 2.50 | ||||
| AVTE | Aerovate Therapeutics | 1.55 | ||||
| TCRX | Tscan Therapeutics | 0.39 | ||||
| ANIX | Anixa Biosciences | 2.00 | ||||
| ANTX | AN2 Therapeutics | 2.56 | ||||
| AVXL | Anavex Life | 3.13 | ||||
| ANEB | Anebulo Pharmaceuticals | 3.14 | ||||
| BIVI | Biovie | 3.47 | ||||
| PYPD | PolyPid | 4.35 | ||||
| CGTX | Cognition Therapeutics | 6.49 |
Complementary Tools for INmune Stock analysis
When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |